Manifestation of Herpetic Eye Disease after COVID-19 Vaccine: A UK Case Series

References

• https://www.worldometers.info/coronavirus/. Accessed October 02, 2021.
   Google Scholar
• Singh S, Roy D, Sinha K, Parveen S, Sharma G, Joshi G. Impact of COVID-19 and lockdown on mental health of children and adolescents: a narrative review with recommendations. Psychiatry Res. 2020;293:113429. doi:10.1016/j.psychres.2020.113429.
   PubMed Web of Science ®Google Scholar
• Ting DSJ, Deshmukh R, Said DG, Dua HS. The impact of COVID-19 pandemic on ophthalmology services: are we ready for the aftermath? Ther Adv Ophthalmol. 2020;12:2515841420964099. doi:10.1177/2515841420964099.
   Web of Science ®Google Scholar
• Ting DSJ, Krause S, Said DG, Dua HS. Psychosocial impact of COVID-19 pandemic lockdown on people living with eye diseases in the UK. Eye (Lond). 2021;35:2064–2066. doi:10.1038/s41433-020-01130-4.
   PubMed Web of Science ®Google Scholar
• Cutler DM, Summers LH. The COVID-19 pandemic and the $16 trillion virus. JAMA. 2020;324:1495–1496. doi:10.1001/jama.2020.19759.
   PubMed Web of Science ®Google Scholar
• Gunasekeran DV, Tseng R, Tham YC, Wong TY. Applications of digital health for public health responses to COVID-19: a systematic scoping review of artificial intelligence, telehealth and related technologies. NPJ Digit Med. 2021;4:40. doi:10.1038/s41746-021-00412-9.
   PubMed Web of Science ®Google Scholar
• Tan TE, Chodosh J, McLeod SD, et al. Global trends in ophthalmic practices in response to COVID-19. Ophthalmology. 2021;128:1505–1515. doi:10.1016/j.ophtha.2021.07.027.
   PubMed Web of Science ®Google Scholar
• Ho CS, Avery AJ, Livingstone IAT, Ting DSJ. Virtual consultation for red eye. BMJ. 2021;373:n1490. doi:10.1136/bmj.n1490.
   PubMedGoogle Scholar
• Rampat R, Deshmukh R, Chen X, et al. Artificial intelligence in cornea, refractive surgery, and cataract: basic principles, clinical applications, and future directions. Asia Pac J Ophthalmol (Phila). 2021;10:268–281. doi:10.1097/APO.0000000000000394.
   PubMed Web of Science ®Google Scholar
• https://www.worldbank.org/en/about/what-we-do/brief/world-bank-group-operational-response-covid-19-coronavirus-projects-list. Accessed October 02, 2021.
   Google Scholar
• https://ourworldindata.org/covid-vaccinations. Accessed October 02, 2021.
   Google Scholar
• The Lancet H. COVID-19 vaccines: building and maintaining confidence. Lancet Haematol. 2021;8:e305. doi:10.1016/S2352-3026(21)00107-1.
   PubMed Web of Science ®Google Scholar
• Anand P, Stahel VP. Review the safety of Covid-19 mRNA vaccines: a review. Patient Saf Surg. 2021;15:20. doi:10.1186/s13037-021-00291-9.
   PubMed Web of Science ®Google Scholar
• Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383:2603–2615. doi:10.1056/NEJMoa2034577.
   PubMed Web of Science ®Google Scholar
• Rheumatology TL. COVID-19 vaccine data provide reassurance. Lancet Rheumatol. 2021;3:e605. doi:10.1016/S2665-9913(21)00255-1.
   PubMedGoogle Scholar
• World Health Organization. Coronavirus disease (COVID-19): herd immunity, lockdowns and COVID-19. 2021. https://www.whoint/news-room/qa-detail/herd-immunity-lockdowns-and-covid-19. Accessed October 02, 2021.
   Google Scholar
• Schultz NH, Sorvoll IH, Michelsen AE, et al. Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 vaccination. N Engl J Med. 2021;384:2124–2130. doi:10.1056/NEJMoa2104882.
   PubMed Web of Science ®Google Scholar
• Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. 2021;384:2092–2101. doi:10.1056/NEJMoa2104840.
   PubMed Web of Science ®Google Scholar
• Klein NP, Lewis N, Goddard K, et al. Surveillance for adverse events after COVID-19 mRNA vaccination. JAMA. 2021;326:1390–1399. doi:10.1001/jama.2021.15072.
   PubMed Web of Science ®Google Scholar
• Ng XL, Betzler BK, Testi I, et al. Ocular adverse events after COVID-19 vaccination. Ocul Immunol Inflamm. 2021:1–9. doi:10.1080/09273948.2020.1849735.
   PubMedGoogle Scholar
• Pichi F, Aljneibi S, Neri P, Hay S, Dackiw C, Ghazi NG. Association of ocular adverse events with inactivated COVID-19 vaccination in patients in Abu Dhabi. JAMA Ophthalmol. 2021;139:1131–1135. doi:10.1001/jamaophthalmol.2021.3477.
   PubMed Web of Science ®Google Scholar
• Phylactou M, Li JO, Larkin DFP. Characteristics of endothelial corneal transplant rejection following immunisation with SARS-CoV-2 messenger RNA vaccine. Br J Ophthalmol. 2021;105:893–896. doi:10.1136/bjophthalmol-2021-319338.
   PubMed Web of Science ®Google Scholar
• Rallis KI, Ting DSJ, Said DG, Dua HS. Corneal graft rejection following COVID-19 vaccine. Eye (Lond). 2021. doi:10.1038/s41433-021-01671-2.
   PubMedGoogle Scholar
• Cheng JY, Margo CE. Ocular adverse events following vaccination: overview and update. Surv Ophthalmol. 2021;67:293–306. S0039-6257(21)00099-0. doi:10.1016/j.survophthal.2021.04.001.
   PubMed Web of Science ®Google Scholar
• Hwang CW Jr., Steigleman WA, Saucedo-Sanchez E, Tuli SS. Reactivation of herpes zoster keratitis in an adult after varicella zoster vaccination. Cornea. 2013;32:508–509. doi:10.1097/ICO.0b013e318277acae.
   PubMed Web of Science ®Google Scholar
• Nagpal A, Vora R, Margolis TP, Acharya NR. Interstitial keratitis following varicella vaccination. Arch Ophthalmol. 2009;127:222–223. doi:10.1001/archophthalmol.2008.569.
   PubMedGoogle Scholar
• Fulginiti VA, Papier A, Lane JM, Neff JM, Henderson DA. Smallpox vaccination: a review, part II. Adverse events. Clin Infect Dis. 2003;37:251–271. doi:10.1086/375825.
   PubMed Web of Science ®Google Scholar
• Ferrini W, Aubert V, Balmer A, Munier FL, Abouzeid H. Anterior uveitis and cataract after rubella vaccination: a case report of a 12-month-old girl. Pediatrics. 2013;132:e1035–8. doi:10.1542/peds.2012-2930.
   PubMed Web of Science ®Google Scholar
• Nguyen LN, Parikh SU, Batliwala SY, Davis AS, Riaz KM. Temporal profile and treatment of purpureocillium lilacinum keratitis secondary to herpes zoster reactivation following influenza vaccination. Int Med Case Rep J. 2020;13:455–459. doi:10.2147/IMCRJ.S265724.
   PubMed Web of Science ®Google Scholar
• Ting DSJ, Ho CS, Deshmukh R, Said DG, Dua HS. Infectious keratitis: an update on epidemiology, causative microorganisms, risk factors, and antimicrobial resistance. Eye (Lond). 2021;35:1084–1101. doi:10.1038/s41433-020-01339-3.
   PubMed Web of Science ®Google Scholar
• Young RC, Hodge DO, Liesegang TJ, Baratz KH. Incidence, recurrence, and outcomes of herpes simplex virus eye disease in Olmsted County, Minnesota, 1976-2007: the effect of oral antiviral prophylaxis. Arch Ophthalmol. 2010;128:1178–1183. doi:10.1001/archophthalmol.2010.187.
   PubMedGoogle Scholar
• Ting DSJ, Ghosh N, Ghosh S. Herpes zoster ophthalmicus. BMJ. 2019;364:k5234. doi:10.1136/bmj.k5234.
   PubMedGoogle Scholar
• Baird NL, Zhu S, Pearce CM, Viejo-Borbolla A. Current in vitro models to study varicella zoster virus latency and reactivation. Viruses . 2019;11(2):103.
   Web of Science ®Google Scholar
• Thomas SL, Hall AJ. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis. 2004;4:26–33. doi:10.1016/S1473-3099(03)00857-0.
   PubMed Web of Science ®Google Scholar
• Blondeau JM, Aoki FY, Glavin GB. Stress-induced reactivation of latent herpes simplex virus infection in rat lumbar dorsal root ganglia. J Psychosom Res. 1993;37:843–849. doi:10.1016/0022-3999(93)90173-D.
   PubMed Web of Science ®Google Scholar
• Zaal MJ, Volker-Dieben HJ, Wienesen M, D’Amaro J, Kijlstra A. Longitudinal analysis of varicella-zoster virus DNA on the ocular surface associated with herpes zoster ophthalmicus. Am J Ophthalmol. 2001;131:25–29. doi:10.1016/S0002-9394(00)00652-8.
   PubMed Web of Science ®Google Scholar
• Salerno-Goncalves R, Sztein MB. Cell-mediated immunity and the challenges for vaccine development. Trends Microbiol. 2006;14:536–542. doi:10.1016/j.tim.2006.10.004.
   PubMed Web of Science ®Google Scholar
• Maia CMF, Marques NP, de Lucena EHG, de Rezende LF, Martelli DRB, Martelli-Junior H. Increased number of Herpes Zoster cases in Brazil related to the COVID-19 pandemic. Int J Infect Dis. 2021;104:732–733. doi:10.1016/j.ijid.2021.02.033.
   PubMed Web of Science ®Google Scholar
• Tartari F, Spadotto A, Zengarini C, et al. Herpes zoster in COVID-19-positive patients. Int J Dermatol. 2020;59:1028–1029. doi:10.1111/ijd.15001.
   PubMed Web of Science ®Google Scholar
• Menni C, Klaser K, May A, et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. Lancet Infect Dis. 2021;21:939–949. doi:10.1016/S1473-3099(21)00224-3.
   PubMed Web of Science ®Google Scholar
• Andrzejczak-Grządko S, Czudy Z, Donderska M. Side effects after COVID-19 vaccinations among residents of Poland. Eur Rev Med Pharmacol Sci. 2021;25:4418–4421. doi:10.26355/eurrev_202106_26153.
   PubMed Web of Science ®Google Scholar
• Mahallawi WH, Mumena WA. Reactogenicity and Immunogenicity of the Pfizer and AstraZeneca COVID-19 Vaccines. Front Immunol. 2021;12:794642. doi:10.3389/fimmu.2021.794642.
   PubMed Web of Science ®Google Scholar
• Watad A, De Marco G, Mahajna H, et al. Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA/DNA SARS-CoV-2 vaccination. Vaccines (Basel). 2021;9:435. doi:10.3390/vaccines9050435.
   PubMed Web of Science ®Google Scholar
• Teijaro JR, Farber DL. COVID-19 vaccines: modes of immune activation and future challenges. Nat Rev Immunol. 2021;21:195–197. doi:10.1038/s41577-021-00526-x.
   PubMed Web of Science ®Google Scholar